Complete Story
 

01/20/2021

MSHO Featured Corporate Sponsor Assistance Program

Adaptive Biotechnologies

Adaptive Assist Logo 2 ColorAdaptive Biotechnologies understands that each patient's situation is unique. We are committed to providing guidance and support during each step of the insurance process.

That's why we offer the Adaptive Assist program: to help facilitate access to clonoSEQ testing services for patients who could benefit from the clinical insights provided by next-generation measurable residual (MRD) testing.

To visit the Website CLICK HERE



MSHO will profile a different Corporate Sponsor Assistance Program in each Bulletin. To view more Patient Assistance Programs, click here.

Printer-Friendly Version



Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it! 
Report Broken Link